Global Polio Vaccine Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
Summary
Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.
The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2016.
According to APO Research, The global Polio Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
North American market for Polio Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Polio Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Polio Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Polio Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Polio Vaccine include Sanofi, GSK, Bibcol, Serum Institute, Tiantan Biological, IMBCA, Panacea Biotec Ltd, Bio-Med and Halfkin Bio-Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Polio Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Polio Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Polio Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Polio Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Polio Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Polio Vaccine sales, projected growth trends, production technology, application and end-user industry.
Polio Vaccine segment by Company
1. To analyze and research the global Polio Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Polio Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Polio Vaccine significant trends, drivers, influence factors in global and regions.
6. To analyze Polio Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Polio Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Polio Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Polio Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Polio Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Polio Vaccine industry.
Chapter 3: Detailed analysis of Polio Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Polio Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Polio Vaccine in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.
The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2016.
According to APO Research, The global Polio Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
North American market for Polio Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Polio Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Polio Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Polio Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Polio Vaccine include Sanofi, GSK, Bibcol, Serum Institute, Tiantan Biological, IMBCA, Panacea Biotec Ltd, Bio-Med and Halfkin Bio-Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Polio Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Polio Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Polio Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Polio Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Polio Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Polio Vaccine sales, projected growth trends, production technology, application and end-user industry.
Polio Vaccine segment by Company
- Sanofi
- GSK
- Bibcol
- Serum Institute
- Tiantan Biological
- IMBCA
- Panacea Biotec Ltd
- Bio-Med
- Halfkin Bio-Pharmaceuticals
- Inactivated Polio Vaccine (IPV)
- Oral Polio Vaccine (OPV)
- Public
- Private
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global Polio Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Polio Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Polio Vaccine significant trends, drivers, influence factors in global and regions.
6. To analyze Polio Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Polio Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Polio Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Polio Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Polio Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Polio Vaccine industry.
Chapter 3: Detailed analysis of Polio Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Polio Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Polio Vaccine in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Polio Vaccine Sales Value (2019-2030)
1.2.2 Global Polio Vaccine Sales Volume (2019-2030)
1.2.3 Global Polio Vaccine Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 POLIO VACCINE MARKET DYNAMICS
2.1 Polio Vaccine Industry Trends
2.2 Polio Vaccine Industry Drivers
2.3 Polio Vaccine Industry Opportunities and Challenges
2.4 Polio Vaccine Industry Restraints
3 POLIO VACCINE MARKET BY COMPANY
3.1 Global Polio Vaccine Company Revenue Ranking in 2023
3.2 Global Polio Vaccine Revenue by Company (2019-2024)
3.3 Global Polio Vaccine Sales Volume by Company (2019-2024)
3.4 Global Polio Vaccine Average Price by Company (2019-2024)
3.5 Global Polio Vaccine Company Ranking, 2022 VS 2023 VS 2024
3.6 Global Polio Vaccine Company Manufacturing Base & Headquarters
3.7 Global Polio Vaccine Company, Product Type & Application
3.8 Global Polio Vaccine Company Commercialization Time
3.9 Market Competitive Analysis
3.9.1 Global Polio Vaccine Market CR5 and HHI
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.9.3 2023 Polio Vaccine Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion
4 POLIO VACCINE MARKET BY TYPE
4.1 Polio Vaccine Type Introduction
4.1.1 Inactivated Polio Vaccine (IPV)
4.1.2 Oral Polio Vaccine (OPV)
4.2 Global Polio Vaccine Sales Volume by Type
4.2.1 Global Polio Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)
4.2.2 Global Polio Vaccine Sales Volume by Type (2019-2030)
4.2.3 Global Polio Vaccine Sales Volume Share by Type (2019-2030)
4.3 Global Polio Vaccine Sales Value by Type
4.3.1 Global Polio Vaccine Sales Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global Polio Vaccine Sales Value by Type (2019-2030)
4.3.3 Global Polio Vaccine Sales Value Share by Type (2019-2030)
5 POLIO VACCINE MARKET BY APPLICATION
5.1 Polio Vaccine Application Introduction
5.1.1 Public
5.1.2 Private
5.2 Global Polio Vaccine Sales Volume by Application
5.2.1 Global Polio Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)
5.2.2 Global Polio Vaccine Sales Volume by Application (2019-2030)
5.2.3 Global Polio Vaccine Sales Volume Share by Application (2019-2030)
5.3 Global Polio Vaccine Sales Value by Application
5.3.1 Global Polio Vaccine Sales Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global Polio Vaccine Sales Value by Application (2019-2030)
5.3.3 Global Polio Vaccine Sales Value Share by Application (2019-2030)
6 POLIO VACCINE MARKET BY REGION
6.1 Global Polio Vaccine Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Polio Vaccine Sales by Region (2019-2030)
6.2.1 Global Polio Vaccine Sales by Region: 2019-2024
6.2.2 Global Polio Vaccine Sales by Region (2025-2030)
6.3 Global Polio Vaccine Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global Polio Vaccine Sales Value by Region (2019-2030)
6.4.1 Global Polio Vaccine Sales Value by Region: 2019-2024
6.4.2 Global Polio Vaccine Sales Value by Region (2025-2030)
6.5 Global Polio Vaccine Market Price Analysis by Region (2019-2024)
6.6 North America
6.6.1 North America Polio Vaccine Sales Value (2019-2030)
6.6.2 North America Polio Vaccine Sales Value Share by Country, 2023 VS 2030
6.7 Europe
6.7.1 Europe Polio Vaccine Sales Value (2019-2030)
6.7.2 Europe Polio Vaccine Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
6.8.1 Asia-Pacific Polio Vaccine Sales Value (2019-2030)
6.8.2 Asia-Pacific Polio Vaccine Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
6.9.1 Latin America Polio Vaccine Sales Value (2019-2030)
6.9.2 Latin America Polio Vaccine Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
6.10.1 Middle East & Africa Polio Vaccine Sales Value (2019-2030)
6.10.2 Middle East & Africa Polio Vaccine Sales Value Share by Country, 2023 VS 2030
7 POLIO VACCINE MARKET BY COUNTRY
7.1 Global Polio Vaccine Sales by Country: 2019 VS 2023 VS 2030
7.2 Global Polio Vaccine Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global Polio Vaccine Sales by Country (2019-2030)
7.3.1 Global Polio Vaccine Sales by Country (2019-2024)
7.3.2 Global Polio Vaccine Sales by Country (2025-2030)
7.4 Global Polio Vaccine Sales Value by Country (2019-2030)
7.4.1 Global Polio Vaccine Sales Value by Country (2019-2024)
7.4.2 Global Polio Vaccine Sales Value by Country (2025-2030)
7.5 USA
7.5.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
7.5.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
7.6 Canada
7.6.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
7.6.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
7.7 Germany
7.7.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
7.7.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
7.8 France
7.8.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
7.8.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
7.9.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
7.9.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
7.10 Italy
7.10.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
7.10.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
7.11.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
7.11.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
7.12.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
7.12.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
7.13 China
7.13.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
7.13.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
7.14 Japan
7.14.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
7.14.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
7.15.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
7.15.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
7.16.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
7.16.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
7.17 India
7.17.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
7.17.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
7.18 Australia
7.18.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
7.18.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
7.19.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
7.19.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
7.20.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
7.20.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
7.21.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
7.21.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
7.22.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
7.22.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
7.22.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
7.23 UAE
7.23.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
7.23.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
7.23.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 Sanofi
8.1.1 Sanofi Comapny Information
8.1.2 Sanofi Business Overview
8.1.3 Sanofi Polio Vaccine Sales, Value and Gross Margin (2019-2024)
8.1.4 Sanofi Polio Vaccine Product Portfolio
8.1.5 Sanofi Recent Developments
8.2 GSK
8.2.1 GSK Comapny Information
8.2.2 GSK Business Overview
8.2.3 GSK Polio Vaccine Sales, Value and Gross Margin (2019-2024)
8.2.4 GSK Polio Vaccine Product Portfolio
8.2.5 GSK Recent Developments
8.3 Bibcol
8.3.1 Bibcol Comapny Information
8.3.2 Bibcol Business Overview
8.3.3 Bibcol Polio Vaccine Sales, Value and Gross Margin (2019-2024)
8.3.4 Bibcol Polio Vaccine Product Portfolio
8.3.5 Bibcol Recent Developments
8.4 Serum Institute
8.4.1 Serum Institute Comapny Information
8.4.2 Serum Institute Business Overview
8.4.3 Serum Institute Polio Vaccine Sales, Value and Gross Margin (2019-2024)
8.4.4 Serum Institute Polio Vaccine Product Portfolio
8.4.5 Serum Institute Recent Developments
8.5 Tiantan Biological
8.5.1 Tiantan Biological Comapny Information
8.5.2 Tiantan Biological Business Overview
8.5.3 Tiantan Biological Polio Vaccine Sales, Value and Gross Margin (2019-2024)
8.5.4 Tiantan Biological Polio Vaccine Product Portfolio
8.5.5 Tiantan Biological Recent Developments
8.6 IMBCA
8.6.1 IMBCA Comapny Information
8.6.2 IMBCA Business Overview
8.6.3 IMBCA Polio Vaccine Sales, Value and Gross Margin (2019-2024)
8.6.4 IMBCA Polio Vaccine Product Portfolio
8.6.5 IMBCA Recent Developments
8.7 Panacea Biotec Ltd
8.7.1 Panacea Biotec Ltd Comapny Information
8.7.2 Panacea Biotec Ltd Business Overview
8.7.3 Panacea Biotec Ltd Polio Vaccine Sales, Value and Gross Margin (2019-2024)
8.7.4 Panacea Biotec Ltd Polio Vaccine Product Portfolio
8.7.5 Panacea Biotec Ltd Recent Developments
8.8 Bio-Med
8.8.1 Bio-Med Comapny Information
8.8.2 Bio-Med Business Overview
8.8.3 Bio-Med Polio Vaccine Sales, Value and Gross Margin (2019-2024)
8.8.4 Bio-Med Polio Vaccine Product Portfolio
8.8.5 Bio-Med Recent Developments
8.9 Halfkin Bio-Pharmaceuticals
8.9.1 Halfkin Bio-Pharmaceuticals Comapny Information
8.9.2 Halfkin Bio-Pharmaceuticals Business Overview
8.9.3 Halfkin Bio-Pharmaceuticals Polio Vaccine Sales, Value and Gross Margin (2019-2024)
8.9.4 Halfkin Bio-Pharmaceuticals Polio Vaccine Product Portfolio
8.9.5 Halfkin Bio-Pharmaceuticals Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Polio Vaccine Value Chain Analysis
9.1.1 Polio Vaccine Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Polio Vaccine Sales Mode & Process
9.2 Polio Vaccine Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Polio Vaccine Distributors
9.2.3 Polio Vaccine Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Polio Vaccine Sales Value (2019-2030)
1.2.2 Global Polio Vaccine Sales Volume (2019-2030)
1.2.3 Global Polio Vaccine Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 POLIO VACCINE MARKET DYNAMICS
2.1 Polio Vaccine Industry Trends
2.2 Polio Vaccine Industry Drivers
2.3 Polio Vaccine Industry Opportunities and Challenges
2.4 Polio Vaccine Industry Restraints
3 POLIO VACCINE MARKET BY COMPANY
3.1 Global Polio Vaccine Company Revenue Ranking in 2023
3.2 Global Polio Vaccine Revenue by Company (2019-2024)
3.3 Global Polio Vaccine Sales Volume by Company (2019-2024)
3.4 Global Polio Vaccine Average Price by Company (2019-2024)
3.5 Global Polio Vaccine Company Ranking, 2022 VS 2023 VS 2024
3.6 Global Polio Vaccine Company Manufacturing Base & Headquarters
3.7 Global Polio Vaccine Company, Product Type & Application
3.8 Global Polio Vaccine Company Commercialization Time
3.9 Market Competitive Analysis
3.9.1 Global Polio Vaccine Market CR5 and HHI
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.9.3 2023 Polio Vaccine Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion
4 POLIO VACCINE MARKET BY TYPE
4.1 Polio Vaccine Type Introduction
4.1.1 Inactivated Polio Vaccine (IPV)
4.1.2 Oral Polio Vaccine (OPV)
4.2 Global Polio Vaccine Sales Volume by Type
4.2.1 Global Polio Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)
4.2.2 Global Polio Vaccine Sales Volume by Type (2019-2030)
4.2.3 Global Polio Vaccine Sales Volume Share by Type (2019-2030)
4.3 Global Polio Vaccine Sales Value by Type
4.3.1 Global Polio Vaccine Sales Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global Polio Vaccine Sales Value by Type (2019-2030)
4.3.3 Global Polio Vaccine Sales Value Share by Type (2019-2030)
5 POLIO VACCINE MARKET BY APPLICATION
5.1 Polio Vaccine Application Introduction
5.1.1 Public
5.1.2 Private
5.2 Global Polio Vaccine Sales Volume by Application
5.2.1 Global Polio Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)
5.2.2 Global Polio Vaccine Sales Volume by Application (2019-2030)
5.2.3 Global Polio Vaccine Sales Volume Share by Application (2019-2030)
5.3 Global Polio Vaccine Sales Value by Application
5.3.1 Global Polio Vaccine Sales Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global Polio Vaccine Sales Value by Application (2019-2030)
5.3.3 Global Polio Vaccine Sales Value Share by Application (2019-2030)
6 POLIO VACCINE MARKET BY REGION
6.1 Global Polio Vaccine Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Polio Vaccine Sales by Region (2019-2030)
6.2.1 Global Polio Vaccine Sales by Region: 2019-2024
6.2.2 Global Polio Vaccine Sales by Region (2025-2030)
6.3 Global Polio Vaccine Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global Polio Vaccine Sales Value by Region (2019-2030)
6.4.1 Global Polio Vaccine Sales Value by Region: 2019-2024
6.4.2 Global Polio Vaccine Sales Value by Region (2025-2030)
6.5 Global Polio Vaccine Market Price Analysis by Region (2019-2024)
6.6 North America
6.6.1 North America Polio Vaccine Sales Value (2019-2030)
6.6.2 North America Polio Vaccine Sales Value Share by Country, 2023 VS 2030
6.7 Europe
6.7.1 Europe Polio Vaccine Sales Value (2019-2030)
6.7.2 Europe Polio Vaccine Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
6.8.1 Asia-Pacific Polio Vaccine Sales Value (2019-2030)
6.8.2 Asia-Pacific Polio Vaccine Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
6.9.1 Latin America Polio Vaccine Sales Value (2019-2030)
6.9.2 Latin America Polio Vaccine Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
6.10.1 Middle East & Africa Polio Vaccine Sales Value (2019-2030)
6.10.2 Middle East & Africa Polio Vaccine Sales Value Share by Country, 2023 VS 2030
7 POLIO VACCINE MARKET BY COUNTRY
7.1 Global Polio Vaccine Sales by Country: 2019 VS 2023 VS 2030
7.2 Global Polio Vaccine Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global Polio Vaccine Sales by Country (2019-2030)
7.3.1 Global Polio Vaccine Sales by Country (2019-2024)
7.3.2 Global Polio Vaccine Sales by Country (2025-2030)
7.4 Global Polio Vaccine Sales Value by Country (2019-2030)
7.4.1 Global Polio Vaccine Sales Value by Country (2019-2024)
7.4.2 Global Polio Vaccine Sales Value by Country (2025-2030)
7.5 USA
7.5.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
7.5.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
7.6 Canada
7.6.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
7.6.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
7.7 Germany
7.7.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
7.7.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
7.8 France
7.8.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
7.8.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
7.9.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
7.9.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
7.10 Italy
7.10.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
7.10.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
7.11.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
7.11.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
7.12.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
7.12.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
7.13 China
7.13.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
7.13.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
7.14 Japan
7.14.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
7.14.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
7.15.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
7.15.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
7.16.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
7.16.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
7.17 India
7.17.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
7.17.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
7.18 Australia
7.18.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
7.18.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
7.19.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
7.19.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
7.20.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
7.20.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
7.21.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
7.21.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
7.22.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
7.22.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
7.22.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
7.23 UAE
7.23.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
7.23.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
7.23.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 Sanofi
8.1.1 Sanofi Comapny Information
8.1.2 Sanofi Business Overview
8.1.3 Sanofi Polio Vaccine Sales, Value and Gross Margin (2019-2024)
8.1.4 Sanofi Polio Vaccine Product Portfolio
8.1.5 Sanofi Recent Developments
8.2 GSK
8.2.1 GSK Comapny Information
8.2.2 GSK Business Overview
8.2.3 GSK Polio Vaccine Sales, Value and Gross Margin (2019-2024)
8.2.4 GSK Polio Vaccine Product Portfolio
8.2.5 GSK Recent Developments
8.3 Bibcol
8.3.1 Bibcol Comapny Information
8.3.2 Bibcol Business Overview
8.3.3 Bibcol Polio Vaccine Sales, Value and Gross Margin (2019-2024)
8.3.4 Bibcol Polio Vaccine Product Portfolio
8.3.5 Bibcol Recent Developments
8.4 Serum Institute
8.4.1 Serum Institute Comapny Information
8.4.2 Serum Institute Business Overview
8.4.3 Serum Institute Polio Vaccine Sales, Value and Gross Margin (2019-2024)
8.4.4 Serum Institute Polio Vaccine Product Portfolio
8.4.5 Serum Institute Recent Developments
8.5 Tiantan Biological
8.5.1 Tiantan Biological Comapny Information
8.5.2 Tiantan Biological Business Overview
8.5.3 Tiantan Biological Polio Vaccine Sales, Value and Gross Margin (2019-2024)
8.5.4 Tiantan Biological Polio Vaccine Product Portfolio
8.5.5 Tiantan Biological Recent Developments
8.6 IMBCA
8.6.1 IMBCA Comapny Information
8.6.2 IMBCA Business Overview
8.6.3 IMBCA Polio Vaccine Sales, Value and Gross Margin (2019-2024)
8.6.4 IMBCA Polio Vaccine Product Portfolio
8.6.5 IMBCA Recent Developments
8.7 Panacea Biotec Ltd
8.7.1 Panacea Biotec Ltd Comapny Information
8.7.2 Panacea Biotec Ltd Business Overview
8.7.3 Panacea Biotec Ltd Polio Vaccine Sales, Value and Gross Margin (2019-2024)
8.7.4 Panacea Biotec Ltd Polio Vaccine Product Portfolio
8.7.5 Panacea Biotec Ltd Recent Developments
8.8 Bio-Med
8.8.1 Bio-Med Comapny Information
8.8.2 Bio-Med Business Overview
8.8.3 Bio-Med Polio Vaccine Sales, Value and Gross Margin (2019-2024)
8.8.4 Bio-Med Polio Vaccine Product Portfolio
8.8.5 Bio-Med Recent Developments
8.9 Halfkin Bio-Pharmaceuticals
8.9.1 Halfkin Bio-Pharmaceuticals Comapny Information
8.9.2 Halfkin Bio-Pharmaceuticals Business Overview
8.9.3 Halfkin Bio-Pharmaceuticals Polio Vaccine Sales, Value and Gross Margin (2019-2024)
8.9.4 Halfkin Bio-Pharmaceuticals Polio Vaccine Product Portfolio
8.9.5 Halfkin Bio-Pharmaceuticals Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Polio Vaccine Value Chain Analysis
9.1.1 Polio Vaccine Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Polio Vaccine Sales Mode & Process
9.2 Polio Vaccine Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Polio Vaccine Distributors
9.2.3 Polio Vaccine Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
LIST OF TABLES
Table 1. Polio Vaccine Industry Trends
Table 2. Polio Vaccine Industry Drivers
Table 3. Polio Vaccine Industry Opportunities and Challenges
Table 4. Polio Vaccine Industry Restraints
Table 5. Global Polio Vaccine Revenue by Company (US$ Million) & (2019-2024)
Table 6. Global Polio Vaccine Revenue Share by Company (2019-2024)
Table 7. Global Polio Vaccine Sales Volume by Company (M Doses) & (2019-2024)
Table 8. Global Polio Vaccine Sales Volume Share by Company (2019-2024)
Table 9. Global Polio Vaccine Average Price (USD/K Doses) of Company (2019-2024)
Table 10. Global Polio Vaccine Company Ranking, 2022 VS 2023 VS 2024 & (US$ Million)
Table 11. Global Polio Vaccine Key Company Manufacturing Base & Headquarters
Table 12. Global Polio Vaccine Company, Product Type & Application
Table 13. Global Polio Vaccine Company Commercialization Time
Table 14. Global Company Market Concentration Ratio (CR5 and HHI)
Table 15. Global Polio Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2023)
Table 16. Mergers & Acquisitions, Expansion
Table 17. Major Companies of Inactivated Polio Vaccine (IPV)
Table 18. Major Companies of Oral Polio Vaccine (OPV)
Table 19. Global Polio Vaccine Sales Volume by Type 2019 VS 2023 VS 2030 (M Doses)
Table 20. Global Polio Vaccine Sales Volume by Type (2019-2024) & (M Doses)
Table 21. Global Polio Vaccine Sales Volume by Type (2025-2030) & (M Doses)
Table 22. Global Polio Vaccine Sales Volume Share by Type (2019-2024)
Table 23. Global Polio Vaccine Sales Volume Share by Type (2025-2030)
Table 24. Global Polio Vaccine Sales Value by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 25. Global Polio Vaccine Sales Value by Type (2019-2024) & (US$ Million)
Table 26. Global Polio Vaccine Sales Value by Type (2025-2030) & (US$ Million)
Table 27. Global Polio Vaccine Sales Value Share by Type (2019-2024)
Table 28. Global Polio Vaccine Sales Value Share by Type (2025-2030)
Table 29. Major Companies of Public
Table 30. Major Companies of Private
Table 31. Global Polio Vaccine Sales Volume by Application 2019 VS 2023 VS 2030 (M Doses)
Table 32. Global Polio Vaccine Sales Volume by Application (2019-2024) & (M Doses)
Table 33. Global Polio Vaccine Sales Volume by Application (2025-2030) & (M Doses)
Table 34. Global Polio Vaccine Sales Volume Share by Application (2019-2024)
Table 35. Global Polio Vaccine Sales Volume Share by Application (2025-2030)
Table 36. Global Polio Vaccine Sales Value by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 37. Global Polio Vaccine Sales Value by Application (2019-2024) & (US$ Million)
Table 38. Global Polio Vaccine Sales Value by Application (2025-2030) & (US$ Million)
Table 39. Global Polio Vaccine Sales Value Share by Application (2019-2024)
Table 40. Global Polio Vaccine Sales Value Share by Application (2025-2030)
Table 41. Global Polio Vaccine Sales by Region: 2019 VS 2023 VS 2030 (M Doses)
Table 42. Global Polio Vaccine Sales by Region (2019-2024) & (M Doses)
Table 43. Global Polio Vaccine Sales Market Share by Region (2019-2024)
Table 44. Global Polio Vaccine Sales by Region (2025-2030) & (M Doses)
Table 45. Global Polio Vaccine Sales Market Share by Region (2025-2030)
Table 46. Global Polio Vaccine Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 47. Global Polio Vaccine Sales Value by Region (2019-2024) & (US$ Million)
Table 48. Global Polio Vaccine Sales Value Share by Region (2019-2024)
Table 49. Global Polio Vaccine Sales Value by Region (2025-2030) & (US$ Million)
Table 50. Global Polio Vaccine Sales Value Share by Region (2025-2030)
Table 51. Global Polio Vaccine Market Average Price (USD/K Doses) by Region (2019-2024)
Table 52. Global Polio Vaccine Market Average Price (USD/K Doses) by Region (2025-2030)
Table 53. Global Polio Vaccine Sales by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 54. Global Polio Vaccine Sales Value by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 55. Global Polio Vaccine Sales by Country (2019-2024) & (M Doses)
Table 56. Global Polio Vaccine Sales Market Share by Country (2019-2024)
Table 57. Global Polio Vaccine Sales by Country (2025-2030) & (M Doses)
Table 58. Global Polio Vaccine Sales Market Share by Country (2025-2030)
Table 59. Global Polio Vaccine Sales Value by Country (2019-2024) & (US$ Million)
Table 60. Global Polio Vaccine Sales Value Market Share by Country (2019-2024)
Table 61. Global Polio Vaccine Sales Value by Country (2025-2030) & (US$ Million)
Table 62. Global Polio Vaccine Sales Value Market Share by Country (2025-2030)
Table 63. Sanofi Company Information
Table 64. Sanofi Business Overview
Table 65. Sanofi Polio Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 66. Sanofi Polio Vaccine Product Portfolio
Table 67. Sanofi Recent Development
Table 68. GSK Company Information
Table 69. GSK Business Overview
Table 70. GSK Polio Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 71. GSK Polio Vaccine Product Portfolio
Table 72. GSK Recent Development
Table 73. Bibcol Company Information
Table 74. Bibcol Business Overview
Table 75. Bibcol Polio Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 76. Bibcol Polio Vaccine Product Portfolio
Table 77. Bibcol Recent Development
Table 78. Serum Institute Company Information
Table 79. Serum Institute Business Overview
Table 80. Serum Institute Polio Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 81. Serum Institute Polio Vaccine Product Portfolio
Table 82. Serum Institute Recent Development
Table 83. Tiantan Biological Company Information
Table 84. Tiantan Biological Business Overview
Table 85. Tiantan Biological Polio Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 86. Tiantan Biological Polio Vaccine Product Portfolio
Table 87. Tiantan Biological Recent Development
Table 88. IMBCA Company Information
Table 89. IMBCA Business Overview
Table 90. IMBCA Polio Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 91. IMBCA Polio Vaccine Product Portfolio
Table 92. IMBCA Recent Development
Table 93. Panacea Biotec Ltd Company Information
Table 94. Panacea Biotec Ltd Business Overview
Table 95. Panacea Biotec Ltd Polio Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 96. Panacea Biotec Ltd Polio Vaccine Product Portfolio
Table 97. Panacea Biotec Ltd Recent Development
Table 98. Bio-Med Company Information
Table 99. Bio-Med Business Overview
Table 100. Bio-Med Polio Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 101. Bio-Med Polio Vaccine Product Portfolio
Table 102. Bio-Med Recent Development
Table 103. Halfkin Bio-Pharmaceuticals Company Information
Table 104. Halfkin Bio-Pharmaceuticals Business Overview
Table 105. Halfkin Bio-Pharmaceuticals Polio Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 106. Halfkin Bio-Pharmaceuticals Polio Vaccine Product Portfolio
Table 107. Halfkin Bio-Pharmaceuticals Recent Development
Table 108. Key Raw Materials
Table 109. Raw Materials Key Suppliers
Table 110. Polio Vaccine Distributors List
Table 111. Polio Vaccine Customers List
Table 112. Research Programs/Design for This Report
Table 113. Authors List of This Report
Table 114. Secondary Sources
Table 115. Primary Sources
Table 1. Polio Vaccine Industry Trends
Table 2. Polio Vaccine Industry Drivers
Table 3. Polio Vaccine Industry Opportunities and Challenges
Table 4. Polio Vaccine Industry Restraints
Table 5. Global Polio Vaccine Revenue by Company (US$ Million) & (2019-2024)
Table 6. Global Polio Vaccine Revenue Share by Company (2019-2024)
Table 7. Global Polio Vaccine Sales Volume by Company (M Doses) & (2019-2024)
Table 8. Global Polio Vaccine Sales Volume Share by Company (2019-2024)
Table 9. Global Polio Vaccine Average Price (USD/K Doses) of Company (2019-2024)
Table 10. Global Polio Vaccine Company Ranking, 2022 VS 2023 VS 2024 & (US$ Million)
Table 11. Global Polio Vaccine Key Company Manufacturing Base & Headquarters
Table 12. Global Polio Vaccine Company, Product Type & Application
Table 13. Global Polio Vaccine Company Commercialization Time
Table 14. Global Company Market Concentration Ratio (CR5 and HHI)
Table 15. Global Polio Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2023)
Table 16. Mergers & Acquisitions, Expansion
Table 17. Major Companies of Inactivated Polio Vaccine (IPV)
Table 18. Major Companies of Oral Polio Vaccine (OPV)
Table 19. Global Polio Vaccine Sales Volume by Type 2019 VS 2023 VS 2030 (M Doses)
Table 20. Global Polio Vaccine Sales Volume by Type (2019-2024) & (M Doses)
Table 21. Global Polio Vaccine Sales Volume by Type (2025-2030) & (M Doses)
Table 22. Global Polio Vaccine Sales Volume Share by Type (2019-2024)
Table 23. Global Polio Vaccine Sales Volume Share by Type (2025-2030)
Table 24. Global Polio Vaccine Sales Value by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 25. Global Polio Vaccine Sales Value by Type (2019-2024) & (US$ Million)
Table 26. Global Polio Vaccine Sales Value by Type (2025-2030) & (US$ Million)
Table 27. Global Polio Vaccine Sales Value Share by Type (2019-2024)
Table 28. Global Polio Vaccine Sales Value Share by Type (2025-2030)
Table 29. Major Companies of Public
Table 30. Major Companies of Private
Table 31. Global Polio Vaccine Sales Volume by Application 2019 VS 2023 VS 2030 (M Doses)
Table 32. Global Polio Vaccine Sales Volume by Application (2019-2024) & (M Doses)
Table 33. Global Polio Vaccine Sales Volume by Application (2025-2030) & (M Doses)
Table 34. Global Polio Vaccine Sales Volume Share by Application (2019-2024)
Table 35. Global Polio Vaccine Sales Volume Share by Application (2025-2030)
Table 36. Global Polio Vaccine Sales Value by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 37. Global Polio Vaccine Sales Value by Application (2019-2024) & (US$ Million)
Table 38. Global Polio Vaccine Sales Value by Application (2025-2030) & (US$ Million)
Table 39. Global Polio Vaccine Sales Value Share by Application (2019-2024)
Table 40. Global Polio Vaccine Sales Value Share by Application (2025-2030)
Table 41. Global Polio Vaccine Sales by Region: 2019 VS 2023 VS 2030 (M Doses)
Table 42. Global Polio Vaccine Sales by Region (2019-2024) & (M Doses)
Table 43. Global Polio Vaccine Sales Market Share by Region (2019-2024)
Table 44. Global Polio Vaccine Sales by Region (2025-2030) & (M Doses)
Table 45. Global Polio Vaccine Sales Market Share by Region (2025-2030)
Table 46. Global Polio Vaccine Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 47. Global Polio Vaccine Sales Value by Region (2019-2024) & (US$ Million)
Table 48. Global Polio Vaccine Sales Value Share by Region (2019-2024)
Table 49. Global Polio Vaccine Sales Value by Region (2025-2030) & (US$ Million)
Table 50. Global Polio Vaccine Sales Value Share by Region (2025-2030)
Table 51. Global Polio Vaccine Market Average Price (USD/K Doses) by Region (2019-2024)
Table 52. Global Polio Vaccine Market Average Price (USD/K Doses) by Region (2025-2030)
Table 53. Global Polio Vaccine Sales by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 54. Global Polio Vaccine Sales Value by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 55. Global Polio Vaccine Sales by Country (2019-2024) & (M Doses)
Table 56. Global Polio Vaccine Sales Market Share by Country (2019-2024)
Table 57. Global Polio Vaccine Sales by Country (2025-2030) & (M Doses)
Table 58. Global Polio Vaccine Sales Market Share by Country (2025-2030)
Table 59. Global Polio Vaccine Sales Value by Country (2019-2024) & (US$ Million)
Table 60. Global Polio Vaccine Sales Value Market Share by Country (2019-2024)
Table 61. Global Polio Vaccine Sales Value by Country (2025-2030) & (US$ Million)
Table 62. Global Polio Vaccine Sales Value Market Share by Country (2025-2030)
Table 63. Sanofi Company Information
Table 64. Sanofi Business Overview
Table 65. Sanofi Polio Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 66. Sanofi Polio Vaccine Product Portfolio
Table 67. Sanofi Recent Development
Table 68. GSK Company Information
Table 69. GSK Business Overview
Table 70. GSK Polio Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 71. GSK Polio Vaccine Product Portfolio
Table 72. GSK Recent Development
Table 73. Bibcol Company Information
Table 74. Bibcol Business Overview
Table 75. Bibcol Polio Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 76. Bibcol Polio Vaccine Product Portfolio
Table 77. Bibcol Recent Development
Table 78. Serum Institute Company Information
Table 79. Serum Institute Business Overview
Table 80. Serum Institute Polio Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 81. Serum Institute Polio Vaccine Product Portfolio
Table 82. Serum Institute Recent Development
Table 83. Tiantan Biological Company Information
Table 84. Tiantan Biological Business Overview
Table 85. Tiantan Biological Polio Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 86. Tiantan Biological Polio Vaccine Product Portfolio
Table 87. Tiantan Biological Recent Development
Table 88. IMBCA Company Information
Table 89. IMBCA Business Overview
Table 90. IMBCA Polio Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 91. IMBCA Polio Vaccine Product Portfolio
Table 92. IMBCA Recent Development
Table 93. Panacea Biotec Ltd Company Information
Table 94. Panacea Biotec Ltd Business Overview
Table 95. Panacea Biotec Ltd Polio Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 96. Panacea Biotec Ltd Polio Vaccine Product Portfolio
Table 97. Panacea Biotec Ltd Recent Development
Table 98. Bio-Med Company Information
Table 99. Bio-Med Business Overview
Table 100. Bio-Med Polio Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 101. Bio-Med Polio Vaccine Product Portfolio
Table 102. Bio-Med Recent Development
Table 103. Halfkin Bio-Pharmaceuticals Company Information
Table 104. Halfkin Bio-Pharmaceuticals Business Overview
Table 105. Halfkin Bio-Pharmaceuticals Polio Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 106. Halfkin Bio-Pharmaceuticals Polio Vaccine Product Portfolio
Table 107. Halfkin Bio-Pharmaceuticals Recent Development
Table 108. Key Raw Materials
Table 109. Raw Materials Key Suppliers
Table 110. Polio Vaccine Distributors List
Table 111. Polio Vaccine Customers List
Table 112. Research Programs/Design for This Report
Table 113. Authors List of This Report
Table 114. Secondary Sources
Table 115. Primary Sources
LIST OF FIGURES
Figure 1. Polio Vaccine Product Picture
Figure 2. Global Polio Vaccine Sales Value (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Polio Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Polio Vaccine Sales (2019-2030) & (M Doses)
Figure 5. Global Polio Vaccine Sales Average Price (USD/K Doses) & (2019-2030)
Figure 6. Global Polio Vaccine Company Revenue Ranking in 2023 (US$ Million)
Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2023 (US$ Million)
Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 9. Inactivated Polio Vaccine (IPV) Picture
Figure 10. Oral Polio Vaccine (OPV) Picture
Figure 11. Global Polio Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (M Doses)
Figure 12. Global Polio Vaccine Sales Volume Share 2019 VS 2023 VS 2030
Figure 13. Global Polio Vaccine Sales Volume Share by Type (2019-2030)
Figure 14. Global Polio Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Polio Vaccine Sales Value Share 2019 VS 2023 VS 2030
Figure 16. Global Polio Vaccine Sales Value Share by Type (2019-2030)
Figure 17. Public Picture
Figure 18. Private Picture
Figure 19. Global Polio Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (M Doses)
Figure 20. Global Polio Vaccine Sales Volume Share 2019 VS 2023 VS 2030
Figure 21. Global Polio Vaccine Sales Volume Share by Application (2019-2030)
Figure 22. Global Polio Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 23. Global Polio Vaccine Sales Value Share 2019 VS 2023 VS 2030
Figure 24. Global Polio Vaccine Sales Value Share by Application (2019-2030)
Figure 25. Global Polio Vaccine Sales by Region: 2019 VS 2023 VS 2030 (M Doses)
Figure 26. Global Polio Vaccine Sales Market Share by Region: 2019 VS 2023 VS 2030
Figure 27. Global Polio Vaccine Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 28. Global Polio Vaccine Sales Value Share by Region: 2019 VS 2023 VS 2030
Figure 29. North America Polio Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 30. North America Polio Vaccine Sales Value Share by Country (%), 2023 VS 2030
Figure 31. Europe Polio Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 32. Europe Polio Vaccine Sales Value Share by Country (%), 2023 VS 2030
Figure 33. Asia-Pacific Polio Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Polio Vaccine Sales Value Share by Country (%), 2023 VS 2030
Figure 35. Latin America Polio Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 36. Latin America Polio Vaccine Sales Value Share by Country (%), 2023 VS 2030
Figure 37. Middle East & Africa Polio Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 38. Middle East & Africa Polio Vaccine Sales Value Share by Country (%), 2023 VS 2030
Figure 39. USA Polio Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 40. USA Polio Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 41. USA Polio Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 42. Canada Polio Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 43. Canada Polio Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 44. Canada Polio Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 45. Germany Polio Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 46. Germany Polio Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 47. Germany Polio Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 48. France Polio Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 49. France Polio Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 50. France Polio Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 51. U.K. Polio Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 52. U.K. Polio Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 53. U.K. Polio Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 54. Italy Polio Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 55. Italy Polio Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 56. Italy Polio Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 57. Netherlands Polio Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 58. Netherlands Polio Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 59. Netherlands Polio Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 60. Nordic Countries Polio Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 61. Nordic Countries Polio Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 62. Nordic Countries Polio Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 63. China Polio Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 64. China Polio Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 65. China Polio Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 66. Japan Polio Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 67. Japan Polio Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 68. Japan Polio Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 69. South Korea Polio Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 70. South Korea Polio Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 71. South Korea Polio Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 72. Southeast Asia Polio Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 73. Southeast Asia Polio Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 74. Southeast Asia Polio Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 75. India Polio Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 76. India Polio Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 77. India Polio Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 78. Australia Polio Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 79. Australia Polio Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 80. Australia Polio Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 81. Mexico Polio Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 82. Mexico Polio Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 83. Mexico Polio Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 84. Brazil Polio Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 85. Brazil Polio Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 86. Brazil Polio Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 87. Turkey Polio Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 88. Turkey Polio Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 89. Turkey Polio Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 90. Saudi Arabia Polio Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 91. Saudi Arabia Polio Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 92. Saudi Arabia Polio Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 93. UAE Polio Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 94. UAE Polio Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 95. UAE Polio Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 96. Polio Vaccine Value Chain
Figure 97. Manufacturing Cost Structure
Figure 98. Polio Vaccine Sales Mode & Process
Figure 99. Direct Comparison with Distribution Share
Figure 100. Distributors Profiles
Figure 101. Years Considered
Figure 102. Research Process
Figure 103. Key Executives Interviewed
Figure 1. Polio Vaccine Product Picture
Figure 2. Global Polio Vaccine Sales Value (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Polio Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Polio Vaccine Sales (2019-2030) & (M Doses)
Figure 5. Global Polio Vaccine Sales Average Price (USD/K Doses) & (2019-2030)
Figure 6. Global Polio Vaccine Company Revenue Ranking in 2023 (US$ Million)
Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2023 (US$ Million)
Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 9. Inactivated Polio Vaccine (IPV) Picture
Figure 10. Oral Polio Vaccine (OPV) Picture
Figure 11. Global Polio Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (M Doses)
Figure 12. Global Polio Vaccine Sales Volume Share 2019 VS 2023 VS 2030
Figure 13. Global Polio Vaccine Sales Volume Share by Type (2019-2030)
Figure 14. Global Polio Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Polio Vaccine Sales Value Share 2019 VS 2023 VS 2030
Figure 16. Global Polio Vaccine Sales Value Share by Type (2019-2030)
Figure 17. Public Picture
Figure 18. Private Picture
Figure 19. Global Polio Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (M Doses)
Figure 20. Global Polio Vaccine Sales Volume Share 2019 VS 2023 VS 2030
Figure 21. Global Polio Vaccine Sales Volume Share by Application (2019-2030)
Figure 22. Global Polio Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 23. Global Polio Vaccine Sales Value Share 2019 VS 2023 VS 2030
Figure 24. Global Polio Vaccine Sales Value Share by Application (2019-2030)
Figure 25. Global Polio Vaccine Sales by Region: 2019 VS 2023 VS 2030 (M Doses)
Figure 26. Global Polio Vaccine Sales Market Share by Region: 2019 VS 2023 VS 2030
Figure 27. Global Polio Vaccine Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 28. Global Polio Vaccine Sales Value Share by Region: 2019 VS 2023 VS 2030
Figure 29. North America Polio Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 30. North America Polio Vaccine Sales Value Share by Country (%), 2023 VS 2030
Figure 31. Europe Polio Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 32. Europe Polio Vaccine Sales Value Share by Country (%), 2023 VS 2030
Figure 33. Asia-Pacific Polio Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Polio Vaccine Sales Value Share by Country (%), 2023 VS 2030
Figure 35. Latin America Polio Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 36. Latin America Polio Vaccine Sales Value Share by Country (%), 2023 VS 2030
Figure 37. Middle East & Africa Polio Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 38. Middle East & Africa Polio Vaccine Sales Value Share by Country (%), 2023 VS 2030
Figure 39. USA Polio Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 40. USA Polio Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 41. USA Polio Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 42. Canada Polio Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 43. Canada Polio Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 44. Canada Polio Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 45. Germany Polio Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 46. Germany Polio Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 47. Germany Polio Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 48. France Polio Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 49. France Polio Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 50. France Polio Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 51. U.K. Polio Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 52. U.K. Polio Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 53. U.K. Polio Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 54. Italy Polio Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 55. Italy Polio Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 56. Italy Polio Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 57. Netherlands Polio Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 58. Netherlands Polio Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 59. Netherlands Polio Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 60. Nordic Countries Polio Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 61. Nordic Countries Polio Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 62. Nordic Countries Polio Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 63. China Polio Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 64. China Polio Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 65. China Polio Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 66. Japan Polio Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 67. Japan Polio Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 68. Japan Polio Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 69. South Korea Polio Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 70. South Korea Polio Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 71. South Korea Polio Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 72. Southeast Asia Polio Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 73. Southeast Asia Polio Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 74. Southeast Asia Polio Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 75. India Polio Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 76. India Polio Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 77. India Polio Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 78. Australia Polio Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 79. Australia Polio Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 80. Australia Polio Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 81. Mexico Polio Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 82. Mexico Polio Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 83. Mexico Polio Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 84. Brazil Polio Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 85. Brazil Polio Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 86. Brazil Polio Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 87. Turkey Polio Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 88. Turkey Polio Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 89. Turkey Polio Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 90. Saudi Arabia Polio Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 91. Saudi Arabia Polio Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 92. Saudi Arabia Polio Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 93. UAE Polio Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 94. UAE Polio Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 95. UAE Polio Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 96. Polio Vaccine Value Chain
Figure 97. Manufacturing Cost Structure
Figure 98. Polio Vaccine Sales Mode & Process
Figure 99. Direct Comparison with Distribution Share
Figure 100. Distributors Profiles
Figure 101. Years Considered
Figure 102. Research Process
Figure 103. Key Executives Interviewed
